国产盐酸拓扑替康治疗晚期卵巢癌的疗效观察

目的评价国产盐酸拓扑替康治疗晚期卵巢癌的疗效和安全性。方法对84例晚期卵巢癌患者采用盐酸拓扑替康1.25 mg/m2静滴1-5 d,每21 d重复。治疗2周期后评价疗效,有效病例4周后确认疗效。结果84例中可评价疗效72例,可评价毒性84例。完全缓解2例,部分缓解14例,总有效率22.2%,其中初治和复治患者有效率分别为25.0%和20.8%。主要毒副作用为中性粒细胞减少和白细胞减少,两者III/IV度毒性分别为26.1%和26.1%。非血液学毒性轻微。结论国产盐酸拓扑替康单药治疗晚期卵巢癌,特别是复发病例疗效较好,耐受性良好。

Therapeutic effect of domestic-made topotecan in the treatment of advanced epithelial ovarian carcinoma

Objective To evaluate the efficacy and safety of topotecan(TPT) in the treatment of advanced epithelial ovarian carcinoma. Methods 84 patients with advanced epithelial ovarian carcinoma received TPT(1.25mg/m~2) as a 30-minute infusion daily for 1-5 days,21 days for a cycle.The efficacy was evaluated after 2 cycles of chemotherapy.Response was confirmed 4 weeks later.Results In 84 selected patients,72 were assessable for response and 84 for toxicity.The overall response was 22.2%,including 2 CR and 14 PR.The response rate for untreated and recurrent advanced epithelial ovarian carcinoma was 25.0% and 20.8%,respectively.The main side effects were neutropenia and leukopenia.WHO grade III-IV of them were 26.1% and 26.1%,respectively.The non-hemotological toxicity was mild.Conclusion TPT is effective and well-tolerated in the treatment of advanced epithelial ovarian carcinoma,especially in recurrent patients.